A multidisciplinary team of Weill Cornell Medicine researchers has received a five-year $5.7 million grant from the National Cancer Institute at the National Institutes of Health to fund a center aimed at developing messenger RNA vaccines to deter cancer development in at-risk groups.
There is considerable variation in the management of mantle cell lymphoma across different clinical settings according to an analysis by investigators.
Concern is growing given the sluggish rollout of the coronavirus vaccination distribution in New York. Cynthia Leifer, associate professor of immunology at Cornell University, says vaccines need to be given quickly as possible and rather than disqualifying sites from getting future distributions, expanding the number of distribution locations and incentivizing rapid use is a better solution.
Water shutoffs for non-payment are a constant threat for millions of Americans in any given year. That risk was a deadly one during the pandemic, with access to clean water for handwashing and sanitation a proven way to reduce the spread of COVID-19. The dozens of states that implemented moratoria on water shutoffs to protect vulnerable citizens reported better public health outcomes, according to a new Cornell study.
Cornell professor Jamila Michener testified March 29 before a congressional committee that universal health insurance coverage would not only address health inequities among people of color, but strengthen the U.S. democracy.
Weill Cornell Medicine has been awarded a $9.8 million grant from the National Institutes of Health to lead a consortium of health care institutions that are analyzing nationwide health data in an effort to unravel the complexities of long COVID.
Social justice and engineering blend beautifully. Last semester, Cornell students built a trailblazing food-sharing pantry to take an edge off chronic hunger among local residents.
The researchers used a machine-learning algorithm to spot symptom patterns in the health records of nearly 35,000 U.S. patients who tested positive for SARS-CoV-2 infection and later developed lingering long-COVID-type symptoms.
Dr. Norman Sharpless, director of the National Cancer Institute at the NIH, will give this semester’s Distinguished Lecture in Cancer Biology Sept. 24 from noon-1 p.m.
